9-92306946-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_017948.6(NOL8):āc.2765T>Cā(p.Val922Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00000248 in 1,613,358 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 32)
Exomes š: 0.0000021 ( 0 hom. )
Consequence
NOL8
NM_017948.6 missense
NM_017948.6 missense
Scores
1
8
10
Clinical Significance
Conservation
PhyloP100: 5.51
Genes affected
NOL8 (HGNC:23387): (nucleolar protein 8) NOL8 binds Ras-related GTP-binding proteins (see MIM 608267) and plays a role in cell growth (Sekiguchi et al., 2004 [PubMed 14660641]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.2971857).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NOL8 | NM_017948.6 | c.2765T>C | p.Val922Ala | missense_variant | 11/17 | ENST00000442668.7 | NP_060418.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NOL8 | ENST00000442668.7 | c.2765T>C | p.Val922Ala | missense_variant | 11/17 | 1 | NM_017948.6 | ENSP00000401177.2 | ||
NOL8 | ENST00000542053.5 | c.2561T>C | p.Val854Ala | missense_variant | 10/16 | 5 | ENSP00000440709.1 | |||
NOL8 | ENST00000432670.6 | c.2765T>C | p.Val922Ala | missense_variant | 11/13 | 5 | ENSP00000414112.2 | |||
NOL8 | ENST00000360868.7 | n.*2620T>C | non_coding_transcript_exon_variant | 11/17 | 2 | ENSP00000354115.3 | ||||
NOL8 | ENST00000360868.7 | n.*2620T>C | 3_prime_UTR_variant | 11/17 | 2 | ENSP00000354115.3 | ||||
NOL8 | ENST00000434228.5 | n.*3057T>C | downstream_gene_variant | 2 | ENSP00000415750.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
152216
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248910Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135032
GnomAD3 exomes
AF:
AC:
3
AN:
248910
Hom.:
AF XY:
AC XY:
2
AN XY:
135032
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461142Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 726850
GnomAD4 exome
AF:
AC:
3
AN:
1461142
Hom.:
Cov.:
30
AF XY:
AC XY:
2
AN XY:
726850
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74368
GnomAD4 genome
AF:
AC:
1
AN:
152216
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2024 | The c.2765T>C (p.V922A) alteration is located in exon 11 (coding exon 10) of the NOL8 gene. This alteration results from a T to C substitution at nucleotide position 2765, causing the valine (V) at amino acid position 922 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;T;.;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;T;T;.;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;.;M;.;.;.
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D;D;D;D;N
REVEL
Benign
Sift
Uncertain
D;D;D;D;D;D
Sift4G
Uncertain
D;D;D;D;D;.
Polyphen
P;P;P;.;P;.
Vest4
MutPred
Loss of stability (P = 0.047);.;Loss of stability (P = 0.047);.;.;Loss of stability (P = 0.047);
MVP
MPC
0.18
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at